Aripiprazole reduces liver cell division : research data underlying the article
Pirc Marolt, Tinkara (Author), Kramar, Barbara (Author), Bulc Rozman, Klara (Author), Šuput, Dušan (Author), Milisav, Irina (Author)

.xlsxXLSX - Research data, Download (24,51 KB)
MD5: ADFCEB8D30EF86405F550AE0068B3C29

Effects of aripiprazole on dopamine regulation are being tested as a treatment for patients with a dual diagnosis of schizophrenia and addictions, often cocaine dependence. Aripiprazole has one of the fewest side-effects among the second-generation antipsychotics. Nevertheless, severe aripiprazole hepatotoxicity was reported in persons with a history of cocaine and alcohol abuse. Here we report that therapeutically relevant aripiprazole concentrations, equal to laboratory alert levels in patients’ serum, reduce the rate of hepatocytes’ division. This could be an underlying mechanism of severe liver injury development in the patients with a history of alcohol and cocaine abuse, the two hepatotoxic agents that require increased ability of liver self-regeneration. Monitoring liver functions is, therefore, important in the cases when aripiprazole is co-prescribed or used with drugs with potential hepatotoxic effects.

Keywords:Aripiprazole, Olanzapine, chemical and drug induced liver injury, antipsychotics, second-generation antipsychotics
Organization:MF - Faculty of Medicine
Average score:(0 votes)
Your score:Voting is allowed only to logged in users.
AddThis uses cookies that require your consent. Edit consent...

Document is financed by a project

Funder:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije (ARRS)
Project no.:P3-0019
Name:Aplikativna in bazična fiziologija in patofiziologija v medicini

Funder:EC - European Commission
Funding Programme:H2020
Project no.:721236
Name:Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:


Leave comment

You have to log in to leave a comment.

Comments (0)
0 - 0 / 0
There are no comments!